GlassScriptPhysician profile
Emily Ernst
NPI 1174000178
$7,220.00
in general payments reported to CMS, 2019-2025
58 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,627 · 2022: $3,940 · 2023: $1,133 · 2024: $400 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079 · Education: $374 · Long Term Medical Supply Or Device Loan: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.32 |
| Education | $373.99 |
| Long Term Medical Supply Or Device Loan | $199.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $752.81 | 2021-2024 | |
| Seagen INC. | $566.49 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $521.06 | 2021-2023 | Yervoy |
| Abbvie INC. | $443.10 | 2021-2025 | |
| Astellas Pharma US INC | $428.15 | 2021-2023 | Xtandi |
| Incyte Corporation | $347.82 | 2021-2023 | Jakafi |
| Astrazeneca Pharmaceuticals LP | $286.45 | 2021-2024 | Tagrisso, Lynparza |
| Exelixis INC. | $271.44 | 2021-2023 | |
| Amgen INC. | $263.24 | 2022-2023 | Kyprolis, Blincyto |
| Celgene Corporation | $250.25 | 2021-2024 | Reblozyl, Opdualag |
| Genzyme Corporation | $242.99 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $230.90 | 2021-2025 | Keytruda, Lenvima, Welireg |
| Pfizer INC. | $220.96 | 2021-2024 | |
| Lilly USA, LLC | $213.31 | 2021-2022 | |
| Sobi, INC | $166.85 | 2022-2023 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Ernst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.